New Data Insights from the Phase 3 Teprotumumab Trial (OPTIC) to be Presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Scientific Symposium
DUBLIN--(BUSINESS WIRE)--New data insights from the Phase 3 teprotumumab trial (OPTIC) will be presented at the ASOPRS Fall Scientific Symposium.